Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pneumonol Alergol Pol ; 82(6): 495-502, 2014.
Article in English | MEDLINE | ID: mdl-25339559

ABSTRACT

INTRODUCTION: Non-tuberculous mycobacterial lung diseases (NTMLD) occur rarely and are diagnosed mainly in patients belonging to risk groups. Pulmonary hypertension (PH) has not been recognised as a risk factor for NTMLD yet. The aim of the study was to analyse the clinical course and predisposing factors of NTMLD recognised in our centre between 2002 and 2012 in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH). MATERIAL AND METHODS: Thirteen patients (10 - CTEPH, 3 - IPAH) entered the study. PH was recognised during right heart catheterisation. Median value of mean pulmonary artery pressure (mPAP) was 49 mm Hg (39-65 mm Hg). NTMLD was diagnosed according to ATS guidelines (2007). RESULTS: M. kansasii was the most frequent pathogen. Most patients complained of the exaggeration of dyspnoea and productive cough. Computed tomography of the chest with angiography revealed infiltrations with cavitation in seven patients and cavities surrounded by micronodules in six patients. In all CTEPH patients, NTMLD developed in the hypoperfused lung areas. No parenchymal abnormalities preceded the development of NTMLD. After diagnosis all of the patients received antituberculous treatment; in 12/13 improvement was achieved. By the end of March 2014 seven patients died due to right heart insufficiency, no deaths due to NTMLD were noted. CONCLUSIONS: NTMLD should be suspected in patients with CTEPH or IPAH, presenting with productive cough and a new pulmonary infiltrate with cavitation. In patients with CTEPH, special attention should be paid to a new cavitary lesions without accompanying thrombus in the artery supplying the area. High mPAP (CTEPH/IPAH) and hypoperfusion (CTEPH) are predisposing to NTMLD.


Subject(s)
Familial Primary Pulmonary Hypertension/microbiology , Hypertension, Pulmonary/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Pulmonary Embolism/microbiology , Familial Primary Pulmonary Hypertension/complications , Familial Primary Pulmonary Hypertension/diagnosis , Female , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/drug therapy , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium Infections, Nontuberculous/drug therapy , Nontuberculous Mycobacteria/isolation & purification , Pulmonary Embolism/complications , Pulmonary Embolism/diagnosis
2.
Int J Bioinform Res Appl ; 10(6): 587-612, 2014.
Article in English | MEDLINE | ID: mdl-25335565

ABSTRACT

We proposed here a sequence-based approach predicting some microorganisms as possible sources of autoantigen-related molecular mimicry concerning Idiopathic Pulmonary Arterial Hypertension (IPAH) and related hypertension mostly accompanying autoimmune diseases and AIDS (APAH). This approach (SPECIES_VALENCE) processes the database occurrences of linear autoepitope-related short Dense Quasi-Pattern Sequences (DQPA) generated based on identities of important autoantigenic sequences. The corresponding enumeration comprises two types of statistical evaluations performed in each of eight proposed models. Based on this enumeration, we selected nine microorganisms, whereas revaluation of the obtained scoring values restricted Pseudomonas aeruginosa, Aspergillus fumigatus and the two co-infecting herpes viruses (Epstein Barr virus and cytomegalovirus) as most favourable. The results are discussed in terms of (a) the validity of increased DQPA occurrence in functionally correlated sequences, (b) the possible mechanisms leading to autoantibody response, (c) selected additional pathogenic effects of predicted microorganisms and (d) possible effects of cross-reactivities and immune tolerance.


Subject(s)
Epitopes/genetics , Epitopes/immunology , Familial Primary Pulmonary Hypertension/immunology , Familial Primary Pulmonary Hypertension/microbiology , Molecular Mimicry/immunology , Sequence Analysis, Protein/methods , Amino Acid Sequence , Animals , Conserved Sequence , Epitopes/chemistry , Familial Primary Pulmonary Hypertension/genetics , Humans , Molecular Mimicry/genetics , Molecular Sequence Data , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...